Liver fibrosis secondary to bile duct injury: Correlation of Smad7 with TGF-β and extracellular matrix proteins

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Del Pilar Alatorre Carranza, María ^a   Miranda Díaz, Alejandra ^a   Yañez Sánchez, Irinea ^a   Pizano Martínez, Oscar ^a   Hermosillo Sandoval, José M ^b   Vázquez Del Mercado, Mónica ^a   Hernández Hoyos, Sebastián ^b   Martínez Abundis, Ricardo ^b   Fafutis Morris, Mary ^a   Segura Ortega, Jorge ^a   Delgado Rizo, Vidal ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCLEROPROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; SMAD7 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT INJURY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MALE; NUCLEOTIDE SEQUENCE; ORGAN DONOR; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE LEVEL; BIOPSY; BIOSYNTHESIS; CHOLESTASIS; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; BIOPSY; CHOLESTASIS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 71049171279     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-81     Document Type: Article

References (40)

1. Fabre Y, Bueno MR, Rincon-Sanchez AR, Saldana-Cortes J, Vargas R, Armendariz-Borunda J. Mexican infants with extrahepatic biliary atresia display different fibrosis activity. Hepatol Res 2004, 28:79-86.
2. Mercado MA. Lesión en Vías Biliares. 2005, México, DF: ETM.
3. Bachellier P, Nakano H, Weber JC, Lemarque P, Oussoultzoglou E, Candau C, Wolf P, Jaeck D. Surgical repair after bile duct and vascular injuries during laparoscopic cholecystectomy: when and how?. World J Surg 2001, 25(10):1335-1345. 10.1007/s00268-001-0120-6, 11596900.
4. Fernandez JA, Robles R, Marin C, Sanchez-Bueno F, Ramirez P, Parrilla P. Laparoscopic iatrogeny of the hepatic hilum as an indication for liver transplantation. Liver Transpl 2004, 10(1):147-152. 10.1002/lt.20021, 14755793.
5. Schmidt SC, Langrehr JM, Raakow R, Klupp J, Steinmuller T, Neuhaus P. Right hepatic lobectomy for recurrent cholangitis after combined bile duct and right hepatic artery injury during laparoscopic cholecystectomy: a report of two cases. Langenbecks Arch Surg 2002, 387(3-4):183-187. 10.1007/s00423-002-0300-3, 12172865.
6. Johnson SR, Koehler A, Pennington LK, Hanto DW. Long-term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy. Surgery 2000, 128(4):668-677. 10.1067/msy.2000.108422, 11015101.
7. Rubin E, Gorstein F, Rubin R, Schwarting R, Strayer D. Rubin's Patology: Clinicopatologic Foundations of Medicine. 2005, 1. USA: Lippincott Williams and Wilkins, Fourth.
8. Zakim D, Boyer TD. Hepatology A Textbook of Liver Disease. 2003, 1. USA: SAUNDERS, Fourth.
9. Delgado-Rizo V, Salazar A, Panduro A, Armendariz-Borunda J. Treatment with anti-transforming growth factor beta antibodies influences an altered pattern of cytokines gene expression in injured rat liver. Biochim Biophys Acta 1998, 1442(1):20-27.
10. Hocevar BA, Brown TL, Howe PH. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 1999, 18(5):1345-1356. 1171224, 10064600, 10.1093/emboj/18.5.1345.
11. Inagaki Y, Nemoto T, Nakao A, Dijke P, Kobayashi K, Takehara K, Greenwel P. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription. J Biol Chem 2001, 276(19):16573-16579. 10.1074/jbc.M010485200, 11278686.
12. Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000, 19(8):1745-1754. 302010, 10775259, 10.1093/emboj/19.8.1745.
13. Wehrhan F, Rodel F, Grabenbauer GG, Amann K, Bruckl W, Schultze-Mosgau S. Transforming growth factor beta 1 dependent regulation of Tenascin-C in radiation impaired wound healing. Radiother Oncol 2004, 72(3):297-303. 10.1016/j.radonc.2004.07.011, 15450728.
14. Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001, 276(20):17058-17062. 10.1074/jbc.M100754200, 11279127.
15. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425(6958):577-584. 10.1038/nature02006, 14534577.
16. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002, 35(1):49-61. 10.1053/jhep.2002.30083, 11786959.
17. Monteleone G, Pallone F, MacDonald TT. Smad7 in TGF-beta-mediated negative regulation of gut inflammation. Trends Immunol 2004, 25(10):513-517. 10.1016/j.it.2004.07.008, 15364052.
18. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999, 104(1):5-11. 408403, 10393693, 10.1172/JCI6094.
19. Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma. J Invest Dermatol 2003, 121(1):41-50. 10.1046/j.1523-1747.2003.12308.x, 12839562.
20. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003, 125(1):178-191. 10.1016/S0016-5085(03)00666-8, 12851882.
21. Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ, ten Dijke P, White B, Wigley FM, Goldschmidt-Clermont PJ. Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci USA 2002, 99(6):3908-3913. 122622, 11904440, 10.1073/pnas.062010399.
22. Song SL, Gong ZJ, Zhang QR, Huang TX. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. World J Gastroenterol 2005, 11(15):2269-2276.
23. Chartrand-Lefebvre C, Dufresne MP, Lafortune M, Lapointe R, Dagenais M, Roy A. Iatrogenic injury to the bile duct: a working classification for radiologists. Radiology 1994, 193(2):523-526.
24. Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, ten Dijke P, Gressner AM. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett 2001, 502(1-2):4-10. 10.1016/S0014-5793(01)02656-4, 11478938.
25. Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol 2003, 38(Suppl 1):S38-53. 10.1016/S0168-8278(02)00429-4, 12591185.
26. Lebensztejn DM, Sobaniec-Lotowska M, Kaczmarski M, Werpachowska I, Sienkiewicz J. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B. Hepatogastroenterology 2004, 51(55):229-233.
27. Sakaguchi K, Kitano M, Nishimura M, Senoh T, Ohta T, Terao M, Shinji N, Koide N, Tsuji T. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis. Hepatogastroenterology 2004, 51(60):1780-1783.
28. Biecker E, De Gottardi A, Neef M, Unternahrer M, Schneider V, Ledermann M, Sagesser H, Shaw S, Reichen J. Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms. J Pharmacol Exp Ther 2005, 313(3):952-961. 10.1124/jpet.104.079616, 15769867.
29. Seyhan H, Hamzavi J, Wiercinska E, Gressner AM, Mertens PR, Kopp J, Horch RE, Breitkopf K, Dooley S. Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J Cell Mol Med 2006, 10(4):922-932. 10.1111/j.1582-4934.2006.tb00535.x, 17125595.
30. Ihn H, Yamane K, Tamaki K. Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts. J Invest Dermatol 2005, 125(2):247-255.
31. Sedlaczek N, Jia JD, Bauer M, Herbst H, Ruehl M, Hahn EG, Schuppan D. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 2001, 158(4):1239-1244. 1891909, 11290541.
32. Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, Jang SK, Yang SH, Sung YC, Kwon OJ. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med 2005, 37(2):138-145.
33. Park SH. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol 2005, 38(1):9-16.
34. Kim BC, Lee HJ, Park SH, Lee SR, Karpova TS, McNally JG, Felici A, Lee DK, Kim SJ. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol 2004, 24(6):2251-2262. 355855, 14993265, 10.1128/MCB.24.6.2251-2262.2004.
35. Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol 2007, 27(12):4488-4499. 1900056, 17438144, 10.1128/MCB.01636-06.
36. Geng ZM, Zheng JB, Zhang XX, Tao J, Wang L. Role of transforming growth factor-beta signaling pathway in pathogenesis of benign biliary stricture. World J Gastroenterol 2008, 14(31):4949-4954. 2739950, 18756605, 10.3748/wjg.14.4949.
37. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999, 8(1):93-97. 10.1093/hmg/8.1.93, 9887336.
38. Wang H, Mengsteab S, Tag CG, Gao CF, Hellerbrand C, Lammert F, Gressner AM, Weiskirchen R. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol 2005, 11(13):1929-1936.
39. Li X, Yue ZC, Zhang YY, Bai J, Meng XN, Geng JS, Fu SB. Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer. J Clin Lab Anal 2008, 22(3):164-171. 10.1002/jcla.20236, 18484655.
40. Armendariz-Borunda J, Rincon AR, Munoz-Valle JF, Bueno-Topete M, Oregon-Romero E, Islas-Carbajal MC, Medina-Preciado D, Gonzalez-Garcia I, Bautista CA, Garcia-Rocha S. Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment. J Investig Med 2008, 56(7):944-953.